According to a new report published by Allied Market Research, titled, "Live Cell Imaging Market," The live cell imaging market was valued at $2.3 billion in 2022, and is estimated to reach $5.2 billion by 2032, growing at a CAGR of 8.2% from 2023 to 2032.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Product Type
- Instruments
- Type of Instrument
- Microscopes
- Standalone Systems
- Cell Analyzers
- Accessories and Consumables
- Software
By Application
- Cell Biology
- Stem Cells
- Developmental Biology
- Drug Discovery
By Technology
- Time-lapse Microscopy
- Fluorescence Resonance Energy Transfer (FRET)
- Fluorescence Recovery After Photobleaching (FRAP)
- High-Content Screening (HCS)
- Other Technologies
By End User
- Pharmaceutical and Biotechnological Companies
- Academic and Research Institutes
- Contract Research Organizations
- Others
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- PerkinElmer, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Etaluma, Inc.
- Bruker Corporation
- Merck KGaA
- Sartorius AG
- Carl Zeiss AG
- Nikon Corporation